Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.
Press releases published on September 2, 2025
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease Under Fast Track Status
GlobeNewswire
·
September 2, 2025
TOKYO and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) …
How Sparkvia AI Website Tool Proves Real AI Utility on XRP — SPARK Public Sale is Open for Early Investors
GlobeNewswire
·
September 2, 2025
VALLETTA, Malta, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sparkvia AI has officially opened the public sale of its utility token, SPARK (SPK), at https://sale.sparkvia.ai. The launch follows the debut of Sparkvia’s Website Tool on the XRP Ledger, which …
CEA Industries (BNC) Appoints Seasoned Global Investments Leader, Dr. Russell Read, as Non-Executive Director
GlobeNewswire
·
September 2, 2025
New York, Sept. 02, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq: BNC), (“BNC” or “the Company”), a growth-oriented company focused on managing the world’s largest corporate treasury of BNB, today announced the appointment of Dr. Russell Read, Ph.D …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Outdoor Holding Company Regains Full Compliance with Nasdaq Rule Following Successful Annual Stockholder Meeting
GlobeNewswire
·
September 2, 2025
Scottsdale, Arizona, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Outdoor Holding Company (NASDAQ: POWW/POWWP) (“we,” “us,” “our” or the “Company”), the owner of GunBroker.com, the largest online marketplace for firearms, hunting and related products, today …
Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, …
Korro to Participate in Upcoming Investor and Scientific Conferences
GlobeNewswire
·
September 2, 2025
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that members of management will participate in the following upcoming investor and scientific conferences for the month of September: Citi's 2025 …
Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September
GlobeNewswire
·
September 2, 2025
TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming investor conferences in September as follows: Morgan …
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 54,360 restricted stock units (“RSUs”) and options to purchase 38,850 shares of the Company’s common stock to …
Sanara MedTech Inc. Announces Chief Executive Officer Transition
GlobeNewswire
·
September 2, 2025
Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical …
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
ROCKVILLE, MD, Sept. 02, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that MacroGenics’ President …
Plus Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
HOUSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) …
Nanobiotix to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
PARIS and CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for …
Nanobiotix participera à la conférence investisseurs annuelle H.C. Wainwright global investment
GlobeNewswire
·
September 2, 2025
PARIS et CAMBRIDGE, Mass., 02 sept. 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des approches fondées sur les …
Microchip Technology to Present at the Citi 2025 Global TMT Conference
GlobeNewswire
·
September 2, 2025
CHANDLER, Arizona, Sept. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Citi 2025 Global …
Certara to Participate in Upcoming Investor Conferences
GlobeNewswire
·
September 2, 2025
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: Baird Global Healthcare …
Cycurion to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a premier cybersecurity and IT solutions provider announces that its Chief Executive Officer, Kevin Kelly, and Chief Financial Officer, Alvin McCoy, …
Lifecore Biomedical to Participate in Upcoming Investor Conferences
GlobeNewswire
·
September 2, 2025
CHASKA, Minn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in multiple upcoming …
Diginex Announces move into Digital Asset Sustainability Project Verification; Signs Strategic Alliance with BlockRidge
GlobeNewswire
·
September 2, 2025
LONDON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (NASDAQ: DGNX) (“Diginex”), a leading provider of Sustainability RegTech solutions, and Valuit Technology Delaware LLC (hereinafter referred to as “BlockRidge”), a leading provider of tokenization …
Profusa to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
Berkeley, Calif, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an …